Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicole Renee Leboeuf, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
Cutaneous connective tissue disease associated with immune checkpoint inhibitor therapy: a retrospective analysis
Soma Weiss, 07/01/19 - 06/30/20

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kothakonda A, Atta L, Plana D, Ward F, Davis C, Cramer A, Moran R, Freake J, Tian E, Mazor O, Gorelik P, Van C, Hansen C, Yang H, Sinha MS, Li J, Yu SH, LeBoeuf NR, Sorger PK. De novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic Response. medRxiv. 2021 Mar 29. PMID: 33821290.
    Citations:    
  2. Antonini MJ, Plana D, Srinivasan S, Atta L, Achanta A, Yang H, Cramer AK, Freake J, Sinha MS, Yu SH, LeBoeuf NR, Linville-Engler B, Sorger PK. A Crisis-Responsive Framework for Medical Device Development Applied to the COVID-19 Pandemic. Front Digit Health. 2021 Mar; 3. PMID: 33899045.
    Citations:    
  3. Bui AN, Dee EC, Virgen CA, Lian CG, Devlin PM, LeBoeuf NR. Recalcitrant extramammary Paget's disease treated successfully with high-dose-rate brachytherapy: A case series and review of the literature. Dermatol Ther. 2021 03; 34(2):e14755. PMID: 33406300.
    Citations:    Fields:    Translation:Humans
  4. Cramer AK, Plana D, Yang H, Carmack MM, Tian E, Sinha MS, Krikorian D, Turner D, Mo J, Li J, Gupta R, Manning H, Bourgeois FT, Yu SH, Sorger PK, LeBoeuf NR. Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE. Sci Rep. 2021 01 21; 11(1):2051. PMID: 33479334.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  5. Kassamali B, Yu Z, Davis C, Carmack M, Bui AN, Said JT, Plana D, Yang H, Sorger P, LeBoeuf NR, LaChance AH. Conversion of Existing UVB Phototherapy Units to UVC Germicidal Chambers for N95 Decontamination: Lessons Learned. Photobiomodul Photomed Laser Surg. 2021 Feb; 39(2):83-85. PMID: 33481669.
    Citations:    Fields:    
  6. Hirner J, Cleary JM, Sheets A, Murphy G, LeBoeuf N. Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis. JAMA Dermatol. 2021 01 01; 157(1):119-121. PMID: 33052389.
    Citations:    Fields:    Translation:Humans
  7. Larocca CA, LeBoeuf NR, Silk AW, Kaufman HL. An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions. Am J Clin Dermatol. 2020 Dec; 21(6):821-832. PMID: 32767272.
    Citations: 3     Fields:    
  8. Kacew AJ, Dharaneeswaran H, Starrett GJ, Thakuria M, LeBoeuf NR, Silk AW, DeCaprio JA, Hanna GJ. Predictors of immunotherapy benefit in Merkel cell carcinoma. Oncotarget. 2020 Nov 24; 11(47):4401-4410. PMID: 33315984.
    Citations:    Fields:    
  9. Bui AN, Singer S, Hirner J, Cunningham-Bussel AC, Larocca C, Merola JF, Lian CG, LeBoeuf NR. De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis. J Am Acad Dermatol. 2021 Mar; 84(3):864-869. PMID: 33323344.
    Citations:    Fields:    
  10. Bui AN, Hirner J, Singer SB, Eberly-Puleo A, Larocca C, Lian CG, LeBoeuf NR. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation. Clin Exp Dermatol. 2021 Mar; 46(2):328-337. PMID: 32939795.
    Citations:    Fields:    
  11. Yu Z, Dee EC, Bach DQ, Mostaghimi A, LeBoeuf NR. Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center. JAMA Dermatol. 2020 10 01; 156(10):1079-1085. PMID: 32609305.
    Citations:    Fields:    Translation:Humans
  12. Hanna GJ, Ruiz ES, LeBoeuf NR, Thakuria M, Schmults CD, Decaprio JA, Silk AW. Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI). Br J Cancer. 2020 11; 123(10):1535-1542. PMID: 32868898.
    Citations:    Fields:    Translation:Humans
  13. Tyan K, Levin A, Avalos-Pacheco A, Plana D, Rand EA, Yang H, Maliszewski LE, Chylek LA, Atta L, Tye MA, Carmack MM, Oglesby NS, Burgin S, Yu SH, LeBoeuf NR, Kemp JM. Considerations for the Selection and Use of Disinfectants Against SARS-CoV-2 in a Health Care Setting. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa396. PMID: 32989420.
    Citations:    
  14. Abu-Shawer O, Singh P, Yenulevich E, Brito A, Ni J, Abdulnour RE, Grover S, Manos M, Bowling P, LeBoeuf NR, Ott P, Stephen Hodi F, Jacobson J, Rahma O. Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service. J Immunother Cancer. 2020 08; 8(2). PMID: 32817360.
    Citations: 1     Fields:    
  15. Bui AN, Puleo AE, Canales AL, Jacobsen ED, LeBoeuf NR. Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard. J Drugs Dermatol. 2020 Aug 01; 19(8):803-805. PMID: 32845598.
    Citations:    Fields:    
  16. Plana D, Tian E, Cramer AK, Yang H, Carmack MM, Sinha MS, Bourgeois FT, Yu SH, Masse P, Boyer J, Kim M, Mo J, LeBoeuf NR, Li J, Sorger PK. Assessing the quality of nontraditional N95 filtering face-piece respirators available during the COVID-19 pandemic. medRxiv. 2020 Jul 27. PMID: 32743596.
    Citations:    
  17. McAvoy M, Bui AN, Hansen C, Plana D, Said JT, Yu Z, Yang H, Freake J, Van C, Krikorian D, Cramer A, Smith L, Jiang L, Lee KJ, Li SJ, Beller B, Short M, Yu SH, Mostaghimi A, Sorger PK, LeBoeuf NR. 3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators. medRxiv. 2020 Jul 26. PMID: 32743606.
    Citations:    
  18. Bui AN, LeBoeuf NR, Nambudiri VE. Skin cancer risk in CHEK2 mutation carriers. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):353-359. PMID: 32531112.
    Citations: 1     Fields:    Translation:Humans
  19. Singer S, Tkachenko E, Sharma P, Nelson C, Mostaghimi A, LeBoeuf NR. Geographic Disparities in Access to Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia in the United States. J Am Acad Dermatol. 2020 Jun 28. PMID: 32610170.
    Citations: 1     Fields:    
  20. Bui AN, Yu Z, Lee K, Li SJ, Tsiaras WG, Yu SH, LeBoeuf NR, Mostaghimi A. A pilot study of the impact of facial skin protectants on qualitative fit testing of N95 masks. J Am Acad Dermatol. 2021 Feb; 84(2):554-556. PMID: 32592881.
    Citations: 1     Fields:    
  21. Mostaghimi A, Antonini MJ, Plana D, Anderson PD, Beller B, Boyer EW, Fannin A, Freake J, Oakley R, Sinha MS, Smith L, Van C, Yang H, Sorger PK, LeBoeuf NR, Yu SH. Regulatory and Safety Considerations in Deploying a Locally Fabricated, Reusable Face Shield in a Hospital Responding to the COVID-19 Pandemic. Med (N Y). 2020 Dec 18; 1(1):139-151.e4. PMID: 32838357.
    Citations: 5     
  22. Hanna GJ, Kacew AJ, Tanguturi AR, Grote HJ, Vergara V, Brunkhorst B, Rabinowits G, Thakuria M, LeBoeuf NR, Ihling C, DeCaprio JA, Lorch JH. Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma. Front Med (Lausanne). 2020; 7:198. PMID: 32582722.
    Citations:    
  23. Nelson CA, Singer S, Chen T, Puleo AE, Lian CG, Wei EX, Giobbie-Hurder A, Mostaghimi A, LeBoeuf NR. Reply to: "Comment on Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes". J Am Acad Dermatol. 2020 May 14. PMID: 32417422.
    Citations:    Fields:    
  24. Luskin MR, Kim AS, Patel SS, Wright K, LeBoeuf NR, Lane AA. Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone. Leuk Lymphoma. 2020 09; 61(9):2258-2261. PMID: 32366145.
    Citations: 1     Fields:    Translation:HumansCells
  25. Deutsch A, Leboeuf NR, Lacouture ME, McLellan BN. Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy. Am Soc Clin Oncol Educ Book. 2020 May; 40:485-500. PMID: 32421446.
    Citations: 2     Fields:    Translation:Humans
  26. Anders CK, LeBoeuf NR, Bashoura L, Faiz SA, Shariff AI, Thomas A. What's the Price? Toxicities of Targeted Therapies in Breast Cancer Care. Am Soc Clin Oncol Educ Book. 2020 May; 40:55-70. PMID: 32421449.
    Citations: 1     Fields:    Translation:Humans
  27. Bui AN, Nelson CA, Lian CG, Canales AL, LeBoeuf NR. Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression. JAAD Case Rep. 2020 Aug; 6(8):693-696. PMID: 32715051.
    Citations:    
  28. Cramer AK, Plana D, Yang H, Carmack MM, Tian E, Sinha MS, Krikorian D, Turner D, Mo J, Li J, Gupta R, Manning H, Bourgeois FT, Yu SH, Sorger PK, LeBoeuf NR. Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE: a quality improvement study. medRxiv. 2020 Apr 23. PMID: 32511480.
    Citations:    
  29. Dee EC, Fefer M, Hammoudeh L, Yu Z, Cantalino JM, Johnson TJ, O'Farrell DA, Bui AN, Muralidhar V, Mahal BA, Nguyen PL, LeBoeuf NR, Devlin PM. Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparison. J Am Acad Dermatol. 2021 Jan; 84(1):168-172. PMID: 32320768.
    Citations:    Fields:    
  30. Mostaghimi A, Antonini MJ, Plana D, Anderson PD, Beller B, Boyer EW, Fannin A, Freake J, Oakley R, Sinha MS, Smith L, Van C, Yang H, Sorger PK, LeBoeuf NR, Yu SH. Rapid prototyping and clinical testing of a reusable face shield for health care workers responding to the COVID-19 pandemic. medRxiv. 2020 Apr 15. PMID: 32511612.
    Citations:    
  31. Nomburg J, Bullman S, Chung SS, Togami K, Walker MA, Griffin GK, Morgan EA, LeBoeuf NR, DeCaprio JA, Meyerson M, Lane AA. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2020 03 24; 4(6):1006-1011. PMID: 32182365.
    Citations:    Fields:    Translation:HumansCells
  32. Hirner JP, O'Malley JT, LeBoeuf NR. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective. Hematol Oncol Clin North Am. 2020 06; 34(3):501-509. PMID: 32336415.
    Citations:    Fields:    Translation:HumansCells
  33. Forrest SJ, Al-Ibraheemi A, Doan D, Ward A, Clinton CM, Putra J, Pinches RS, Kadoch C, Chi SN, DuBois SG, Leavey PJ, LeBoeuf NR, Mullen E, Collins N, Church AJ, Janeway KA. Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. Clin Cancer Res. 2020 06 15; 26(12):2882-2890. PMID: 32122923.
    Citations: 1     Fields:    
  34. Nelson CA, Singer S, Chen T, Puleo AE, Lian CG, Wei EX, Giobbie-Hurder A, Mostaghimi A, LeBoeuf NR. Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes. J Am Acad Dermatol. 2020 Jan 10. PMID: 31931083.
    Citations: 5     Fields:    
  35. Shazib MA, Woo SB, Sroussi H, Carvo I, Treister N, Farag A, Schoenfeld J, Haddad R, LeBoeuf N, Villa A. Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series. Oral Dis. 2020 Mar; 26(2):325-333. PMID: 31642136.
    Citations: 1     Fields:    Translation:Humans
  36. Cobos GA, Nelson CA, Alsarheed A, LaChance A, Laga AC, LeBoeuf N, Vleugels RA. Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer. JAMA Dermatol. 2020 01 01; 156(1):103-104. PMID: 31693064.
    Citations:    Fields:    Translation:Humans
  37. Singer S, Tan SY, Dewan AK, Davids M, LaCasce AS, Treon SP, LeBoeuf NR. Cutaneous Eruptions from Ibrutinib Resembling EGFR Inhibitor-Induced Dermatologic Adverse Events. J Am Acad Dermatol. 2019 Dec 20. PMID: 31870917.
    Citations: 1     Fields:    
  38. O'Malley JT, de Masson A, Lowry EL, Giobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res. 2020 01 15; 26(2):408-418. PMID: 31636100.
    Citations: 1     Fields:    Translation:HumansCells
  39. Larocca C, Kupper TS, LeBoeuf NR. Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem. Clin Cancer Res. 2019 12 15; 25(24):7272-7274. PMID: 31615932.
    Citations:    Fields:    Translation:Humans
  40. Singer S, Nelson CA, Lian CG, Dewan AK, LeBoeuf NR. Nonbullous pemphigoid secondary to PD-1 inhibition. JAAD Case Rep. 2019 Oct; 5(10):898-903. PMID: 31646161.
    Citations: 1     
  41. Larocca CA, LeBoeuf NR. Overview of Cutaneous T-Cell Lymphomas. Hematol Oncol Clin North Am. 2019 08; 33(4):669-686. PMID: 31229162.
    Citations:    Fields:    Translation:Humans
  42. Dewan AK, Gupta S, Bach DQ, Jadeja S, Granter S, LaCasce A, Joyce R, Davids MS, Huang V, LeBoeuf NR. Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition. JAAD Case Rep. 2019 May; 5(5):401-405. PMID: 31049381.
    Citations:    
  43. Kacew AJ, Harris EJ, Lorch JH, Haddad RI, Chau NG, Rabinowits G, LeBoeuf NR, Schmults CD, Thakuria M, MacConaill LE, Hanna GJ. Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma. Eur J Cancer. 2019 05; 113:1-9. PMID: 30954880.
    Citations: 6     Fields:    Translation:HumansCells
  44. Asel M, LeBoeuf NR. Extramammary Paget's Disease. Hematol Oncol Clin North Am. 2019 02; 33(1):73-85. PMID: 30497678.
    Citations: 6     Fields:    Translation:Humans
  45. LeBoeuf NR, Larocca C. Cutaneous Malignancy. Hematol Oncol Clin North Am. 2019 02; 33(1):xv-xvi. PMID: 30497681.
    Citations:    Fields:    
  46. Bendapudi PK, Robbins A, LeBoeuf N, Pozdnyakova O, Bhatt A, Duke F, Sells R, McQuiston J, Humrighouse B, Rouaisnel B, Colling M, Stephenson KE, Saavedra A, Losman JA. Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate. Blood Adv. 2018 11 13; 2(21):2917-2921. PMID: 30396911.
    Citations: 2     Fields:    Translation:HumansCells
  47. Dewan AK, Sowerby L, Jadeja S, Lian C, Wen P, Brown JR, Fisher DC, LeBoeuf NR. Pityriasis rubra pilaris-like erythroderma secondary to phosphoinositide 3-kinase inhibition. Clin Exp Dermatol. 2018 Dec; 43(8):890-894. PMID: 29851132.
    Citations: 1     Fields:    Translation:Humans
  48. de Masson A, O'Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, Tawa M, Fisher DC, Devlin PM, Teague JE, Leboeuf NR, Kirsch IR, Robins H, Clark RA, Kupper TS. High-throughput sequencing of the T cell receptor ß gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med. 2018 05 09; 10(440). PMID: 29743350.
    Citations: 14     Fields:    Translation:HumansCells
  49. Alloo A, Khosravi H, Granter SR, Jadeja SM, Richardson PG, Castillo JJ, LeBoeuf NR. Ixazomib-induced cutaneous necrotizing vasculitis. Support Care Cancer. 2018 Jul; 26(7):2247-2250. PMID: 29392482.
    Citations: 1     Fields:    Translation:Humans
  50. Puzanov I, Diab A, Abdallah K, Bingham CO, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. J Immunother Cancer. 2017 11 21; 5(1):95. PMID: 29162153.
    Citations: 337     Fields:    Translation:Humans
  51. Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018 02; 8(2):196-215. PMID: 29101162.
    Citations: 88     Fields:    Translation:HumansAnimalsCells
  52. Sowerby L, Dewan AK, Granter S, Gandhi L, LeBoeuf NR. Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid. JAMA Dermatol. 2017 06 01; 153(6):603-605. PMID: 28355425.
    Citations: 16     Fields:    Translation:Humans
  53. Sauder MB, O'Malley JT, LeBoeuf NR. CD30+ Lymphoproliferative Disorders of the Skin. Hematol Oncol Clin North Am. 2017 04; 31(2):317-334. PMID: 28340881.
    Citations: 4     Fields:    Translation:Humans
  54. Song JS, Tawa M, Chau NG, Kupper TS, LeBoeuf NR. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature. BMC Cancer. 2017 03 16; 17(1):200. PMID: 28302100.
    Citations: 8     Fields:    Translation:HumansCells
  55. Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax. Cancer Discov. 2017 02; 7(2):156-164. PMID: 27986708.
    Citations: 42     Fields:    Translation:HumansAnimalsCells
  56. Tripathi A, Kaymakcalan MD, LeBoeuf NR, Harshman LC. Programmed cell death-1 pathway inhibitors in genitourinary malignancies: specific side-effects and their management. Curr Opin Urol. 2016 11; 26(6):548-55. PMID: 27517638.
    Citations: 3     Fields:    Translation:Humans
  57. Sibaud V, Lebœuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, Montastruc M, Eche A, Vigarios E, Dalenc F, Lacouture ME. Dermatological adverse events with taxane chemotherapy. Eur J Dermatol. 2016 Oct 01; 26(5):427-443. PMID: 27550571.
    Citations: 20     Fields:    Translation:Humans
  58. Paul S, Bach D, LeBoeuf NR, Devlin PM, Lipworth AD. Successful use of brachytherapy for a severe hidradenitis suppurativa variant. Dermatol Ther. 2016 Nov; 29(6):455-458. PMID: 27425163.
    Citations:    Fields:    Translation:Humans
  59. Davids MS, Kim HT, Bachireddy P, Costello C, Liguori R, Savell A, Lukez AP, Avigan D, Chen YB, McSweeney P, LeBoeuf NR, Rooney MS, Bowden M, Zhou CW, Granter SR, Hornick JL, Rodig SJ, Hirakawa M, Severgnini M, Hodi FS, Wu CJ, Ho VT, Cutler C, Koreth J, Alyea EP, Antin JH, Armand P, Streicher H, Ball ED, Ritz J, Bashey A, Soiffer RJ. Ipilimumab for Patients with Relapse after Allogeneic Transplantation. N Engl J Med. 2016 Jul 14; 375(2):143-53. PMID: 27410923.
    Citations: 142     Fields:    Translation:HumansCellsCTClinical Trials
  60. Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, et al. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183. PMID: 27479034.
    Citations: 20     Fields:    
  61. Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, et al. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586. PMID: 27070704.
    Citations: 76     Fields:    Translation:HumansAnimalsCells
  62. Goddard AL, Vleugels RA, LeBoeuf NR, O'Farrell DA, Cormack RA, Hansen JL, Kupper TS, Devlin PM. Palliative Therapy for Recalcitrant Cutaneous T-Cell Lymphoma of the Hands and Feet With Low-Dose, High Dose-Rate Brachytherapy. JAMA Dermatol. 2015 Dec 01; 151(12):1354-1357. PMID: 26397774.
    Citations: 6     Fields:    
  63. Nambudiri VE, Vivero M, Watson AJ, Thakuria M, Ng A, Russell S, Rabinowits G, LeBoeuf NR. Merkel Cell Carcinoma Presenting as Subcutaneous Breast Masses: An Uncommon Presentation of a Rare Neuroendocrine Neoplasm. Breast J. 2016 Jan-Feb; 22(1):113-5. PMID: 26607182.
    Citations: 1     Fields:    Translation:Humans
  64. Kirsch IR, Watanabe R, O'Malley JT, Williamson DW, Scott LL, Elco CP, Teague JE, Gehad A, Lowry EL, LeBoeuf NR, Krueger JG, Robins HS, Kupper TS, Clark RA. TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med. 2015 Oct 07; 7(308):308ra158. PMID: 26446955.
    Citations: 40     Fields:    Translation:HumansCells
  65. Alloo A, Sheu J, Butrynski JE, DeAngelo DJ, George S, Murphy GF, LeBoeuf NR. Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities. Br J Dermatol. 2015 Aug; 173(2):574-7. PMID: 25736577.
    Citations: 6     Fields:    Translation:Humans
  66. Geyer MB, Radhakrishnan K, Giller R, Umegaki N, Harel S, Kiuru M, Morel KD, LeBoeuf N, Kandel J, Bruckner A, Fabricatore S, Chen M, Woodley D, McGrath J, Baxter-Lowe L, Uitto J, Christiano AM, Cairo MS. Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa. J Pediatr. 2015 Sep; 167(3):765-9.e1. PMID: 26148662.
    Citations: 5     Fields:    Translation:HumansCells
  67. Cohen JM, Nambudiri VE, Kulke MH, Todd DJ, Murphy GF, LeBoeuf NR. Cutaneous paraneoplastic granulomatous eruptions secondary to metastatic carcinoid tumour. Br J Dermatol. 2015; 172(5):1451-4. PMID: 25388104.
    Citations:    Fields:    Translation:Humans
  68. LeBoeuf NR, McDermott S, Harris NL. Case records of the Massachusetts General Hospital. Case 5-2015. A 69-year-old woman with recurrent skin lesions after treatment for lymphoma. N Engl J Med. 2015 Feb 12; 372(7):650-9. PMID: 25671258.
    Citations: 1     Fields:    Translation:HumansCells
  69. Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer. 2015 Aug; 23(8):2231-44. PMID: 25564221.
    Citations: 11     Fields:    Translation:Humans
  70. Sheu J, Hawryluk EB, Litsas G, Thakuria M, LeBoeuf NR. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor. Clin Breast Cancer. 2015 Feb; 15(1):e77-81. PMID: 25445421.
    Citations: 1     Fields:    Translation:Humans
  71. Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S. Successful Treatment of a Progressive BRAF V600E-Mutated Anaplastic Pleomorphic Xanthoastrocytoma With Vemurafenib Monotherapy. J Clin Oncol. 2016 Apr 01; 34(10):e87-9. PMID: 25092772.
    Citations: 32     Fields:    Translation:Humans
  72. Thakuria M, LeBoeuf NR, Rabinowits G. Update on the biology and clinical management of Merkel cell carcinoma. Am Soc Clin Oncol Educ Book. 2014; e405-10. PMID: 24857131.
    Citations: 1     Fields:    Translation:HumansCells
  73. Weitz NA, Lauren CT, Weiser JA, LeBoeuf NR, Grossman ME, Biagas K, Garzon MC, Morel KD. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases. JAMA Dermatol. 2013 Feb; 149(2):195-9. PMID: 23560299.
    Citations: 7     Fields:    Translation:Humans
  74. Alloo A, Garibyan L, LeBoeuf N, Lin G, Werchniak A, Hodi FS, Flaherty KT, Lawrence DP, Lin JY. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma. Arch Dermatol. 2012 Mar; 148(3):363-6. PMID: 22431777.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  75. Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS. Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci Transl Med. 2012 Jan 18; 4(117):117ra7. PMID: 22261031.
    Citations: 114     Fields:    Translation:HumansCells
  76. LeBoeuf NR, Schmults CD. Update on the management of high-risk squamous cell carcinoma. Semin Cutan Med Surg. 2011 Mar; 30(1):26-34. PMID: 21540018.
    Citations: 4     Fields:    Translation:Humans
  77. Young AL, Leboeuf NR, Tsiouris SJ, Husain S, Grossman ME. Fatal disseminated Acanthamoeba infection in a liver transplant recipient immunocompromised by combination therapies for graft-versus-host disease. Transpl Infect Dis. 2010 Dec; 12(6):529-37. PMID: 20604904.
    Citations: 7     Fields:    Translation:HumansAnimals
  78. LeBoeuf NR, Lieb J, Grossman ME. Linear erosive herpes simplex virus: the 'knife-cut sign' in a patient on high-dose corticosteroids. Clin Exp Dermatol. 2010 Jul; 35(5):557-8. PMID: 20236288.
    Citations: 1     Fields:    Translation:Humans
  79. Leboeuf NR, Mahalingam M. Acanthomatous superficial sebaceous hamartoma? A study of six cases with clarification of the nomenclature. J Cutan Pathol. 2007 Nov; 34(11):865-70. PMID: 17944728.
    Citations: 3     Fields:    Translation:Humans
  80. LeBoeuf N, Garg A, Worobec S. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Pediatr Dermatol. 2007 Sep-Oct; 24(5):529-33. PMID: 17958803.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Leboeuf's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (165)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.